Mallinckrodt PLC, a specialty pharmaceutical manufacturer that has filed for bankruptcy twice in the past three years, paid more than $21.7 million to three law firms ahead of its second insolvency filing last month.
Bryn Pharma, LLC, a privately held pharmaceutical company dedicated to finding a better way for patients and caregivers to treat anaphylaxis, announced today that it has expanded its leadership team as the company
The company is working towards FDA approval of its epinephrine nasal spray, named UTULY, for treating anaphylaxis. If successful, it may replace the current anaphylaxis treatment standard, which is the needle-based EPIPEN.